glp 1 drugs novo nordisk Novo, Lilly weight-loss should be first option obesity treatments, European doctors say Novo Nordisk said on Tuesday

Also, vestibular disorders emerged early in treatment (median onset: 3.2 months), preceding typical timelines for substantial weight loss effects (612 months)

Electrolytes are not guaranteed to prevent dizziness or fainting, but consuming them on injection day, several hours before your shot, might help

If blood sugar control is your top concern and semaglutide isnt your preference (due to cost or other reasons), metformin is still a go-to option

The unique generation and function of active GLP-1 has influenced growing interest in the hormone, and its reputation as an important biomarker in type 2 diabetes research 16,21,23

The impact of varying the timing of metformin administration on postprandial glucose metabolism is poorly defined